​From 1975 to 1990, mortality rates for US women with breast cancer increased by 0.4% per year. Since then, breast cancer mortality rates have declined between 1.8% and 3.4% per year, resulting in between 384,000 and 614,500 saved lives, according to a new study published in the journal Cancer. "Recent reviews of mammography screening have focused media attention on some of the risks of mammography screening, such as callbacks for additional imaging and breast biopsies, downplaying the most impo...

​The FDA has proposed regulatory amendments to improve the quality of breast cancer screening by expanding the information provided to patients and physicians, modernizing standards for mammograms, and enabling better enforcement of safety and quality regulations. "Breast cancer is one of the most worrisome health concerns facing women. The FDA plays a unique and meaningful role in the delivery of quality mammography to help patients get accurate screening to identify breast health problems...

For the first time in over 20 years, the FDA has proposed amendments to the Mammography Quality Standards Act (MQSA) in an effort to expand the information provided to patients and physicians, modernize standards for mammograms, and enable better enforcement of safety and quality regulations. In this interview with i3 Health, Theresa W. Gillespie, PhD, MA, RN, Professor at Emory University School of Medicine and at Emory's Winship Cancer Institute, discusses the significance of these changes and...